Published in Transplantation on October 01, 1973
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med (1990) 3.73
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med (2007) 3.22
Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A (1996) 2.40
The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. J Immunol (2011) 2.34
A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant (2011) 2.16
Retracted CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice. Clin Exp Immunol (2009) 2.06
Interleukin-17 and its receptor. J Clin Immunol (1997) 2.04
Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med (1978) 1.95
Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81
Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest (1997) 1.77
CD4+ but not CD8+ cells are essential for allorejection. J Exp Med (1996) 1.72
Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model. Am J Transplant (2010) 1.68
Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest (2003) 1.66
Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med (1991) 1.62
Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am J Transplant (2009) 1.59
Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis. J Pathol (2012) 1.57
Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest (2010) 1.55
Epidermal Langerhans cells promote skin allograft rejection in mice with NF-kappa B-impaired T cells. Am J Transplant (2007) 1.55
DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity (2015) 1.54
Split tolerance induced by orthotopic liver transplantation in mice. Transplantation (1994) 1.52
Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog (2011) 1.51
PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J Immunol (2007) 1.51
Hyperlipidemia Promotes Anti-Donor Th17 Responses That Accelerate Allograft Rejection. Am J Transplant (2015) 1.47
Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol (2008) 1.41
Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients. Am J Transplant (2008) 1.39
CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol (2008) 1.36
Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol (2004) 1.34
Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J Exp Med (1985) 1.34
Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol (2008) 1.33
Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure. Am J Transplant (2011) 1.30
TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol (2009) 1.26
The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest (2003) 1.26
Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol (2008) 1.25
B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4. J Clin Invest (2001) 1.24
Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant (2010) 1.23
Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am J Pathol (1994) 1.22
Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am J Pathol (2003) 1.21
The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest (2000) 1.19
Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. Blood (2010) 1.14
IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients. Mol Ther (2012) 1.14
Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am J Transplant (2009) 1.13
New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. Ann Surg (2002) 1.12
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest (2002) 1.12
Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol (2009) 1.12
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol (2007) 1.12
Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Am J Pathol (1998) 1.10
Cognate antigen directs CD8+ T cell migration to vascularized transplants. J Clin Invest (2013) 1.09
Effector functions of donor-reactive CD8 memory T cells are dependent on ICOS induced during division in cardiac grafts. Am J Transplant (2008) 1.08
Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest (2006) 1.08
Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07
Non-self recognition by monocytes initiates allograft rejection. J Clin Invest (2014) 1.06
Donor dendritic cell-derived exosomes promote allograft-targeting immune response. J Clin Invest (2016) 1.03
Preventing Allograft Rejection by Targeting Immune Metabolism. Cell Rep (2015) 1.02
Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner. Am J Transplant (2011) 1.02
Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway. Am J Transplant (2009) 1.02
OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol (2009) 1.01
CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors. J Immunol (2010) 1.01
Role of TNFalpha in early chemokine production and leukocyte infiltration into heart allografts. Am J Transplant (2009) 1.01
Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. Am J Pathol (1998) 1.01
PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant (2009) 1.00
ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS One (2008) 0.99
Tolerance induction or sensitization in mice exposed to noninherited maternal antigens (NIMA). Am J Transplant (2008) 0.99
Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen. Blood (2008) 0.99
Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol (1999) 0.98
Differential expression of microRNAs during allograft rejection. Am J Transplant (2012) 0.98
Interleukin-17 promotes early allograft inflammation. Am J Pathol (2010) 0.97
Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97
The role of MIG/CXCL9 in cardiac allograft vasculopathy. Am J Pathol (2002) 0.97
LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. Am J Transplant (2011) 0.97
Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Am J Pathol (1998) 0.96
Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2. Am J Pathol (2000) 0.95
Regulation of allograft survival by inhibitory FcγRIIb signaling. J Immunol (2012) 0.94
The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93
A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol (2004) 0.93
Paradoxical functions of B7: CD28 costimulation in a MHC class II-mismatched cardiac transplant model. Am J Transplant (2009) 0.93
MHC mismatch inhibits neurogenesis and neuron maturation in stem cell allografts. PLoS One (2011) 0.93
The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy. Am J Transplant (2008) 0.92
Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells. Eur J Immunol (2011) 0.92
Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and perforin. Transplantation (2010) 0.92
Ultra-localization of Foxp3+ T cells within renal allografts shows infiltration of tubules mimicking rejection. Am J Pathol (2007) 0.92
Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: assessment by flow cytometry. Am J Pathol (1998) 0.92
CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival. Transplantation (2009) 0.91
Heterotopic heart transplantation in mice. J Vis Exp (2007) 0.91
Explanation for loss of the HLA matching effect. Transplant Proc (1995) 0.91
Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts. J Surg Res (2011) 0.91
Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts. Transplantation (2011) 0.91
Natural IgM anti-leukocyte autoantibodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17. J Immunol (2012) 0.91
Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection. J Clin Invest (1997) 0.91
History of clinical transplantation. World J Surg (2000) 0.91
IL-6 promotes cardiac graft rejection mediated by CD4+ cells. J Immunol (2011) 0.89
Resistance of Foxp3+ regulatory T cells to Nur77-induced apoptosis promotes allograft survival. PLoS One (2008) 0.89
Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7. Circulation (2012) 0.88
The composition of the microbiota modulates allograft rejection. J Clin Invest (2016) 0.88
Laminins affect T cell trafficking and allograft fate. J Clin Invest (2014) 0.88
Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants. Eur J Immunol (2009) 0.87
Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59
Transplantation of small bowel in the rat: technical and immunological considerations. Surgery (1971) 5.05
Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol (1966) 4.49
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63
Consensus statement on the live organ donor. JAMA (2000) 3.29
Adult Thymectomy: Effect on Recovery from Immunologic Depression in Mice. Science (1965) 2.41
DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT. J Exp Med (1960) 2.35
Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med (1985) 2.34
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22
The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat. J Immunol (1971) 2.17
A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant (2011) 2.16
Heart transplantation in congenic strains of mice. Transplant Proc (1973) 1.97
Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med (1978) 1.95
Reaction of human lymphocytes in culture to components of the medium. Nature (1965) 1.92
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81
Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77
Humoral antibodies in renal allotransplantation in man. N Engl J Med (1970) 1.74
A closer look at water-related geologic activity on Mars. Science (2007) 1.71
Some effects of purified heterologous antihuman lymphocyte serum in man. Transplantation (1967) 1.62
Effect of adult thymectomy on the recovery from immunological depression induced by anti-lymphocyte serum. Surg Forum (1965) 1.60
Athabasca Valles, Mars: a lava-draped channel system. Science (2007) 1.58
Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49
Surgical treatment of acute necrotizing pancreatitis. Ann Surg (1970) 1.49
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48
Technique of simultaneous renal pancreatoduodenal transplantation with urinary drainage of pancreatic secretion. Am J Surg (1987) 1.46
Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol (1994) 1.45
In vivo use of monoclonal antibodies against murine T cell antigens. Clin Immunol Immunopathol (1989) 1.41
Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation (1977) 1.40
All-silica single-mode optical fiber with photonic crystal cladding. Opt Lett (1996) 1.39
Skin graft rejection by beta 2-microglobulin-deficient mice. J Exp Med (1992) 1.37
Surgical treatment of diabetic nephropathy with simultaneous pancreatic duodenal and renal transplantation. Surg Gynecol Obstet (1986) 1.35
Fibronectin is produced by blood vessels in response to injury. J Exp Med (1982) 1.35
Trephine air drill, bronchial brush, and fiberoptic transbronchial lung biopsies in immunosuppressed patients. Am Rev Respir Dis (1977) 1.31
Supercontinuum generation in tapered fibers. Opt Lett (2000) 1.31
Hyperparathyroidism during pregnancy. Am J Surg (1976) 1.29
Kidney transplants between mice of graded immunogenetic diversity. Transplant Proc (1973) 1.29
Peripheral lymphoid development and function in TCR mutant mice. Int Immunol (1994) 1.26
Immunosuppression and temporary skin transplantation in the treatment of massive third degree burns. Ann Surg (1975) 1.26
Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse. J Exp Med (1990) 1.26
Heterologous antilymphocyte sera and some of their effects. Transplantation (1967) 1.25
Removal of 3'-phosphoglycolate from DNA strand-break damage in an oligonucleotide substrate by recombinant human apurinic/apyrimidinic endonuclease 1. Nucleic Acids Res (1994) 1.24
Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation (1986) 1.24
Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med (1994) 1.24
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med (1983) 1.23
Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant (2010) 1.23
Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am J Pathol (1994) 1.22
Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Protective effect of superoxide dismutase. Ann Surg (1985) 1.22
Fine-needle aspiration biopsy in pancreatic transplantation. Transplant Proc (1995) 1.21
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation (1984) 1.20
Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol (1973) 1.19
A technique for reconstruction of the urinary tract in renal transplantation. Surg Gynecol Obstet (1966) 1.19
Temporary skin transplantation and immunosuppression for extensive burns. N Engl J Med (1974) 1.19
The vascular bed as the primary target in the destruction of skin grafts by antiserum. I. Resistance of freshly placed xenografts of skin to antiserum. J Exp Med (1981) 1.18
Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med (1983) 1.18
Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant (2007) 1.18
Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation (1981) 1.18
Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant (2007) 1.17
Induction of IA antigens in murine renal transplants. J Immunol (1985) 1.16
Acute destruction by humoral antibody of rat skin grafted to mice. J Exp Med (1973) 1.15
Analgesia in terminal malignant disease. Br Med J (1979) 1.14
Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma. Transplantation (1994) 1.12
Regulation of human insulin gene expression in transgenic mice. Nature (1986) 1.12
Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation (1989) 1.12
Antilymphocyte serum as an immunosuppressive agent. Ann Intern Med (1968) 1.12
Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Transplantation (1988) 1.12
Studies on natural killer (NK) cells. I. NK cell specific antibodies in CE anti-CBA serum. J Immunol (1981) 1.12
From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation. J Infect Dis (1979) 1.11
Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses. Transplant Proc (1981) 1.11
Endlessly single-mode photonic crystal fiber. Opt Lett (1997) 1.10
Destruction of rat skin grafts by humoral antibody. Transplant Proc (1973) 1.10
The vascular bed as the primary target in the destruction of skin grafts by antiserum. II. Loss of sensitivity to antiserum in long-term xenografts of skin. J Exp Med (1981) 1.10
Variations in the responses of C57BL-10J and A-J mice to sheep red blood cells. J Exp Med (1972) 1.08
Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med (1989) 1.07
A new alloantigenic system associated with the Mls locus in the mouse. J Immunol (1976) 1.07
T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection. Immunol Res (1989) 1.05
The effect of infection on T lymphocyte subpopulations: a preliminary report. Int J Immunopharmacol (1981) 1.04
Acute destruction of rat skin grafts by alloantisera. J Immunol (1975) 1.03
Sensitivity of long-standing xenografts of rat hearts to humoral antibodies. J Immunol (1979) 1.02
Prevalence of eating disorders and psychiatric comorbidity among children and adolescents. Indian Pediatr (2007) 1.02
Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway. Am J Transplant (2009) 1.02
Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation (1982) 1.01
Erythromycin and cyclosporine. Transplantation (1986) 1.01
The renal transplant patient with fever and pulmonary infiltrates: etiology, clinical manifestations, and management. Medicine (Baltimore) (1980) 1.01
Destruction of splenic transplantation antigens by a factor present in liver. J Immunol (1965) 1.01
Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. Surgery (1976) 1.00
Xenon 133 study of ventilation and perfusion in normal and transplanted dog lungs. J Appl Physiol (1967) 0.99
Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon. Ann Intern Med (1980) 0.99